TITLE

Serological and conformational properties of E. coli K92 capsular polysaccharide and its N-propionylated derivative both illustrate that induced antibody does not recognize extended epitopes of polysialic acid: Implications for a comprehensive conjugate vaccine against groups B and C N. meningitidis

AUTHOR(S)
Pon, Robert A; Khieu, Nam Huan; Yang, Qing-Ling; Brisson, Jean-Robert; Jennings, Harold J
PUB. DATE
August 2002
SOURCE
Canadian Journal of Chemistry;Aug2002, Vol. 80 Issue 8, p1055
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The capsular polysaccharide of E. coli K92 (K92P) contains elements in common with the capsular polysaccharides of both groups B and C N. meningitidis, and may therefore form the basis of a bivalent vaccine. In an attempt to augment the cross-protective immune response to group B meningococci, the N-acetyl groups of the K92P were replaced by N-propionyl groups (NPrK92P) and conjugated to protein. This strategy had previously been applied with success to the poorly immunogenic capsular polysaccharide of group B meningococcus (GBMP), and the bactericidal epitope was found to be exclusively mimicked by extended helical segments of the NPrGBMP. The NPrK92P-conjugate, in relation to a K92P-conjugate, failed to enhance the response to GBMP but did generate a measurable response to NPrGBMP, but only at the expense of a greatly reduced GCMP response. Despite the presence of an immune response to NPrGBMP, the anti-NPrK92 serum was not bactericidal. Competitive inhibition studies with NPrGBMP oligosaccharides suggested the NPrK92 antibodies could not cross-react with the protective epitope on group B meningococci, as defined by extended helical segments of the NPrGBMP, but only recognized short non-bactericidal NPrGBMP epitopes. This hypothesis was supported from the conformational and molecular dynamics studies of the K92P, which demonstrated a lack of extended conformations that resemble the GBMP extended epitope. Indeed, the conformational properties of the K92P more closely resembled those of the GCMP, thereby explaining the observed moderate cross-protection of the K92P antiserum towards group C meningococci. Thus, on the basis of these results, it can be concluded that K92P, regardless of N-propionyl modification, will not serve as an effective single vaccine component against both groups B and C meningococci.Key words: conjugate vaccine, Neisseria meningitidis, polysialic acid, NMR, molecular dynamics.Le polysaccharide capsulaire du E. coli K92 (K92P) comprend des éléments communs avec les polysaccharides capsulaires des N. meningitidis des groupes B et C et il pourrait donc être à la base d'un vaccin bivalent. Dans un essai d'augmenter la réponse immunitaire à protection croisée par rapport au méningocoque du groupe B, on a remplacé les groupes N-acétyles du K92P par des groupes N-propionyles (NPrK92P) et on les a conjugués à une protéine. On avait utilisé antérieurement cette stratégie avec succès avec le polysaccharide capsulaire peu immunogène du méningocoque du groupe B (GBMP) et on a trouvé que l'épitope bactéricide n'est répliqué que par des segments hélicoïdaux étendus du NPrGBMP. Par rapport à un conjugué à K92P, le conjugué au NPrK92P n'augmente pas la réponse au GBMP; il provoque toutefois une réponse mesurable au NPrGBMP, mais la réponse au GCMP est toutefois grandement réduite. Malgré la présence d'une réponse immunitaire au NPrGBMP, le sérum anti-NPrK92 n'est pas bactéricide. Des études d'inhibitions compétitives avec des oligosaccharides NPrGBMP suggèrent que les anticorps NPrK92 ne peuvent pas réagir de façon croisée avec l'épitope protecteur des méningocoques du groupe B, tels que définis par des segments hélicoïdaux étendus de NPrGBMP; ils ne reconnaissent que de courtes chaînes d'épitopes NPrGBMP non-bactéricides. Cette hypothèse est confirmée par des études de dynamiques moléculaire et conformationnelle du K92P qui ont démontré l'absence de conformations étendues qui pourraient ressembler à l'épitope étendu du GBMP. Les propriétés conformationnelles du K92P ressemblent en fait beaucoup plus à celles du GCMP; ceci expliquerait la protection croisée modérée observée du sérum K92P vis-à-vis des méningocoques du groupe C. Sur la base de ces résultats, on peut donc conclure que le K92P, même avec une modification N-propionyle, ne pourra pas servir de composant unique d'un vaccin efficace contre les méningocoques des groupes B et C.Mots clés : vaccin conjugué, Neisseria meningitidis, acide polysialique, RMN, dynamique moléculaire.[Traduit par la Rédaction]
ACCESSION #
10585200

 

Related Articles

  • Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Serruto, Davide; Rappuoli, Rino; Scarselli, Maria; Gros, Piet; van Strijp, Jos A. G. // Nature Reviews Microbiology;Jun2010, Vol. 8 Issue 6, p393 

    The complement system is a crucial component of the innate immune response in humans. Recent studies in Staphylococcus aureus and Neisseria meningitidis have revealed how these bacteria escape complement-mediated killing. In addition, new structural data have provided detailed insights into the...

  • NEUTROPHILS IN THE INDUCTION OF IMMUNE RESPONSE AND EFFECTOR CELL AGAINST NEISSERIA MENINGITIDIS B. Lastre, M.; Lapinet, J.; Bracho, G.; Zayas, C.; Díaz, M.; Sierra, G; Cassatella, M. A.; Pérez, O. // Revista VacciMonitor (Vacunología y Temas Afines);Oct2002, Vol. 11 Issue 4, p1 

    The role of neutrophils (PMN) as effector cells against bacterial infection and the production of cytokines in response to polysaccharide (LPS) are well documented. However, no conclusive data of the importance of PMN as effector cell in Neisseria infection and no data about the possible role of...

  • Meningococcal mutagenesis. Novak, Kris // Nature Biotechnology;Nov2000, Vol. 18 Issue 11, p1129 

    Reports on the use of signature tagged mutagenesis to identify genes required for Neisseria meningitides virulence, meningococcal meningitis, according to Christopher Tang and colleagues. Incident leading to the discovery of the gene.

  • Prospective Study of a Serogroup X Neisseria meningitidis Outbreak in Northern Ghana. Gagneux, Sebastein P.; Hodgson, Abraham; Smith, Tom A.; Wirth, Thierry; Ehrhard, Ingrid; Morelli, Giovanna; Genton, Blaise; Binka, Fred N.; Achtman, Mark; Pluschke, Gerd // Journal of Infectious Diseases;3/1/2002, Vol. 185 Issue 5, p618 

    After an epidemic of serogroup A meningococcal meningitis in northern Ghana, a gradual disappearance of the epidemic strain was observed in a series of five 6-month carriage surveys of 37 randomly selected households. As serogroup A Neisseria meningitidis carriage decreased, an epidemic of...

  • AFPL1 AND AFCO1 OVERCOME THYME-INDEPENDENCE OF CAPSULAR POLYSACCHARIDE OF NEISSERIA MENINGITIDIS SEROGROUP C. Romeu, B.; Del Campo, J. M.; Lastre, M.; Cuello, M.; González, E.; Cabrera, O.; Acevedo, R.; Valdés, Y.; Zayas, C.; Balboa, J.; Pérez, O // Revista VacciMonitor (Vacunología y Temas Afines);2010 Supplement 1, Vol. 19, p21 

    T cell independent antigens do not require T cell help to induce immune response, and are not capable to induce immunological memory. To overcome the problem associated with the thyme-independent (TI) nature of polysaccharides (PS) antigens, vaccines strategies have focused on converting the...

  • CHARACTERIZATION AND IMMUNOLOGICAL EVALUATION OF TWO VARIANTS OF THE ENVELOPE DENGUE 2 PROTEIN. Lazo, Laura; Hermida, Lisset; Rodríguez, Rayner; Zulueta, Aída; López, Carlos; Silva, Ricardo; Chinea, Glay; Martín, Jorge; Guzmán, Guadalupe; Guillén, Gerardo // Revista VacciMonitor (Vacunología y Temas Afines);Oct2002, Vol. 11 Issue 4, p1 

    Dengue viruses are the most medical important arthropod-borne flavivirus. Four different serotypes have been identified: DEN 1-DEN 4. The envelope (E) glycoprotein of the virion contains the majority of the determinants involved in the attachment to the host cells as well as the epitopes for...

  • P64K AS A CARRIER PROTEIN OF NEISSERIA MENINGITIDIS PORIN A PEPTIDES. Sardiñas, G.; Gonzalez, S.; Garay, H. E.; Nazábal, C.; Reyes, O.; Silva, R. // Revista VacciMonitor (Vacunología y Temas Afines);Oct2002, Vol. 11 Issue 4, p1 

    Class 1 protein from the outer membrane of N. meningitidis is an attractive target for vaccine development. Previously, cyclic peptides corresponding to VR1 and VR2 regions of the meningococcal class1 protein have been designed and employed as candidate antigens with good results (1). To...

  • ECHO: Pathophysiology of meningococcal meningitis and septicaemia.  // Journal of Clinical Pathology;Dec2003, Vol. 56 Issue 12, p941 

    Many people are nasopharyngeal carries of Neisseria meningitidis but few develop invasive disease. Factors associated with invasion include viral infection, dry dusty air, and passive smoking. Bacterial factors related to invasiveness in the nasopharynx include adhesion factors, IgA protease...

  • Field Evaluation of Two Rapid Diagnostic Tests for Neisseria meningitidis Serogroup A during the 2006 Outbreak in Niger. Rose, Angela M. C.; Gerstl, Sibylle; Mahamane, Ali E.-H.; Sidikou, Fati; Djibo, Saacou; Bonte, Laurence; Caugant, Dominique A.; Guerin, Philippe J.; Chanteau, Suzanne // PLoS ONE;2009, Vol. 4 Issue 10, p1 

    The Pastorex® (BioRad) rapid agglutination test is one of the main rapid diagnostic tests (RDTs) for meningococcal disease currently in use in the ''meningitis belt''. Earlier evaluations, performed after heating and centrifugation of cerebrospinal fluid (CSF) samples, under good laboratory...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics